FB Pixel no scriptKEY STAT | Hillhouse Capital to launch RMB 10 billion fund for startups in China | KrASIA
Visual Stories

KEY STAT | Hillhouse Capital to launch RMB 10 billion fund for startups in China

Written by Julianna Wu Published on 

Medical-related sectors become a popular investment option amid the coronavirus outbreak.

In a move that seems to be defying the mass business halt caused by the coronavirus epidemic, Hillhouse Capital, one of Asia’s biggest investment institutions, announced Monday on its official WeChat account that the company would set up an RMB 10 billion (USD 1.34 billion) fund to support early-stage companies in China.

The fund, named GL Ventures, focuses on four sectors: biomedical and medical equipment, software services and primary technology innovation, consumer internet and technology, as well as emerging consumer brands and services, said its WeChat post.

Hillhouse has been betting on the medtech sector even before the coronavirus outbreak, which has turned the investment spotlight to China’s medical and biomedical industry. In the last quarter of 2019, the Beijing- and Hongkong-based investor shelled out for stakes in three listed medical & biomedical companies, including CBMG, Genmab, and Zai Lab.

With stakes in 16 unicorns, Hillhouse Capital ranks No.15 on Hurun World’s Best Unicorn Investors 2019.


You might like these

  • News

    Singapore’s Motion Ventures completes first close of SGD 30 million debut fund, targeting maritime tech


    Khamila Mulia

    25 Feb 2021    11:17 AM

KrASIA InsightsKrASIA Insights

  • Niki, an AI-enabled household manager for small town consumers, helps users order groceries as well as pay utility bills.


    This voice assistant runs errands for semi-rural users in India | Tales from India’s Towns

    By Avanish Tiwary

    22 Feb 202101:05 AM

Most PopularMost Popular

See All